Companies / Vertex Pharmaceuticals Inc / Ma

Vertex Pharmaceuticals Inc / Ma

Nasdaq: VRTXCIK 875320Health CareBOSTON, MAvrtx.com ↗

Financials · FY2025

Revenue$12.00B
Net income$3.95B
Total debt$105.00M
Cash$6.14B
Diluted EPS$15.32
Shares outstanding253.5M

Ownership

253.5M shares outstanding · as of Jul 31, 2026
0.17%Insiders
Ownership
Insiders0.17%442,945
Institutions92.55%234,571,988
Public float7.28%18,445,991

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 18

View all →
Insider% of sharesShares
Kewalramani ReshmaCEOCEO & President · Director
0.04%98,278
Sachdev AmitEVP Chief Patient & Ext Af Off
0.02%55,570
Wagner Charles F JrEVP, CO & FO
0.02%47,042
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
0.02%46,763
Leiden Jeffrey MExecutive Chairman · Director
0.01%34,797
Altshuler DavidEVP, Chief Scientific Officer
0.01%34,477
Bozic CarmenEVP and CMO
0.01%33,076
Liu JoyEVP and Chief Legal Officer
<0.01%22,811
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
<0.01%18,432
Biller JonathanEVP and Chief Legal Officer
<0.01%13,659

Institutional holders 1,656

View all →
HolderValue% of shares
BlackRock, Inc.$11.98B9.51%
Capital World Investors$11.57B10.06%
Vanguard Group Inc$10.93B9.51%
Capital Research Global Investors$7.85B6.83%
State Street Corporation$5.90B4.68%
JPMORGAN CHASE &amp; CO$2.74B2.38%
Geode Capital Management, LLC$2.73B2.42%
Capital International Investors$2.15B1.87%
Loomis, Sayles &amp; Co., L.P.$1.83B1.59%
AllianceBernstein L.P.$1.77B1.54%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Norges Bank
13F manager
Exit—$-1.44B-3.2M
-100.00%
—
high
Q1 2026
as of
Victory Capital Management, Inc.
13F manager
Trim—$-655.65M-1.5M
-43.74%
1,888,521
0.75% of shares
high
Q1 2026
as of
AllianceBernstein L.P.
13F manager
Trim—$-265.53M-586K
-13.03%
3,910,786
1.54% of shares
high
Q1 2026
as of
Nordea Investment Management AB
13F manager
Trim—$-186.12M-420K
-93.92%
27,171
0.01% of shares
high
Q2 2026
as of
BlackRock, Inc.
13F manager
Add—$177.52M+357K
+1.50%
24,109,373
9.51% of shares
high
Q1 2026
as of
Two Sigma Investments, LP
13F manager
Add—$167.00M+374K
+9000.99%
378,146
0.15% of shares
high
Q1 2026
as of
Millennium Management LLC
13F manager
Trim—$-149.52M-335K
-91.57%
30,823
0.01% of shares
high
Q2 2026
as of
Victory Capital Management, Inc.
13F manager
Add—$141.39M+285K
+15.07%
2,173,152
0.86% of shares
high

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Capital Research Global InvestorsPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
VRTX——92532F100—